Veterinary Oral Ulcer Treatments Market Report 2026

The veterinary oral ulcer treatments market size has grown strongly in recent years. It will grow from $1.1 billion in 2025 to $1.19 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to limited availability of specialized veterinary oral ulcer therapies, high prevalence of untreated oral infections in animals, reliance on conventional antibiotics and antiseptics, lack of targeted oral mucosal drug delivery systems, low awareness of advanced oral care in veterinary practice.

The veterinary oral ulcer treatments market size is expected to see strong growth in the next few years. It will grow to $1.67 billion by 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to advancement in regenerative veterinary medicine, increasing demand for targeted and fast-healing oral therapies, rising adoption of precision drug delivery systems, growing focus on animal welfare and pain management, expansion of biologically active and microbiome-based treatment solutions. Major trends in the forecast period include advanced regenerative oral tissue therapies for accelerated healing of veterinary oral ulcers, increasing adoption of nano-formulated antimicrobial gels for enhanced mucosal penetration in animal oral treatments, rising use of plant-based and bioactive compounds for natural veterinary oral ulcer management, growing development of targeted drug delivery systems for localized oral ulcer treatment in animals, expansion of probiotic and microbiome-modulating therapies for improving oral healing response in veterinary patients.

The expansion of veterinary clinics and hospitals is expected to propel the growth of the veterinary oral ulcer treatments market going forward. Veterinary clinics and hospitals are healthcare facilities where licensed veterinarians provide medical, surgical, and preventive care for animals. The number of veterinary clinics and hospitals is increasing due to rising pet ownership, as more people adopt animals for companionship, which increases demand for routine care, vaccinations, and medical services. The expansion of veterinary clinics improves access to care, resulting in more diagnoses of oral ulcers and a greater demand for related treatments. For instance, in October 2025, according to the American Veterinary Medical Association, in 2023, the US had 34,296 veterinary practices, with each practice generating an average gross revenue of approximately $1.5 million in 2024. Therefore, the expansion of veterinary clinics and hospitals is driving the growth of the veterinary oral ulcer treatments market.

The increasing veterinary healthcare expenditure is expected to propel the growth of the veterinary oral ulcer treatments market going forward. Veterinary healthcare expenditure refers to the total financial resources allocated by governments, organizations, and individuals for the prevention, diagnosis, treatment, and management of animal health and welfare. Veterinary healthcare expenditure is increasing due to the growing prevalence of zoonotic diseases, which is driving higher government and institutional investment in disease surveillance, prevention programs, and veterinary infrastructure to protect both animal and public health. Higher veterinary healthcare expenditure enables clinics to invest in specialized medications, supporting more effective diagnosis and treatment of oral ulcers in animals. For instance, in April 2025, according to the American Animal Hospital Association, spending on veterinary care, including pharmaceuticals and related products dispensed through veterinary clinics in the United States, was projected to total approximately $41.4 billion in 2025. Therefore, the increasing veterinary healthcare expenditure is driving the growth of the veterinary oral ulcer treatments market.

The expansion of livestock farming is expected to propel the growth of the veterinary oral ulcer treatments market going forward. Livestock farming is the practice of raising domesticated animals for products such as food, fibre, and labour under managed agricultural conditions. Livestock farming is increasing primarily due to rising global demand for animal-based foods, as population growth and changing dietary preferences drive higher consumption of meat, milk, and other animal products. The expansion of livestock farming increases the number of animals susceptible to oral diseases, thereby creating a greater need for veterinary oral ulcer treatments to maintain herd health and productivity. For instance, in December 2025, according to the Department of Agriculture, global chicken meat production is projected to increase by about 2% in 2026, reaching a record 109.6 million tons. Additionally, US output is expected to grow by around 1% to 22 million tons. Therefore, the expansion of livestock farming is driving the growth of the veterinary oral ulcer treatments market.

Major companies operating in the veterinary oral ulcer treatments market are Zoetis Inc., Elanco Animal Health Incorporated, Merck & Co. Inc., Virbac SA, Vetoquinol SA, Indian Immunologicals Limited, Rallis India Limited, Ceva Santé Animale Société Anonyme, Alivira Animal Health Limited, Kyoritsu Seiyaku Corporation, Hester Biosciences Limited, Huvepharma EOOD, Norbrook Laboratories Ltd.

North America was the largest region in the veterinary oral ulcer treatments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary oral ulcer treatments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary oral ulcer treatments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary oral ulcer treatments market consists of sales of oral gels, oral sprays, medicated mouth rinses, oral tablets, oral powders, medicated pastes, lozenges, and oral suspensions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.